1887

Abstract

A cell clone persistently infected with human T cell-lymphotrophic virus type IIIB (H3B cells) contained mainly the multiply spliced (2 kb) and singly spliced (4∙3 kb) species of human immunodeficiency virus (HIV) RNA. When H3B cells were co-cultured with susceptible HUT78 cells, cell fusion occurred within 4 h of cell mixing and was accompanied by a marked increase of the unspliced full-length (9∙2 kb) HIV RNA. This first phase of viral RNA induction (4 to 12 h post-infection) was followed by a second phase of viral RNA synthesis from 24 h p.i. in which there were significant increases in all three species of HIV RNA. Reverse transcriptase (RT) inhibitors such as azidothymidine (AZT) at concentrations that abolished HIV DNA synthesis, abolished the first phase but not the second phase of viral RNA synthesis in our model system. A comparable one-step cell-free virus infection showed a pattern of viral RNA synthesis similar to that of the cell-to-cell transmission of infection. However, viral RNA synthesis following cell-free virus infection was totally inhibited by RT inhibitors. The early phase (4 to 12 h) expression of 9∙2 kb HIV RNA is likely to use newly synthesized HIV DNA as template; during this phase, HIV RNA and DNA syntheses occur simultaneously, with each process being dependent on the other for maximal yield. During the later (24 to 48 h) phase, all three HIV RNA species may be transcribed at least in part from proviral DNA from the original donor cells. This later phase may privide one of the mechanisms for natural spread of virus to new cells and for enhanced viral gene expression , despite the presence of AZT.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-1-33
1993-01-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/1/JV0740010033.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-1-33&mimeType=html&fmt=ahah

References

  1. Gough N. 1988; Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Analytical Biochemistry 173:93–95
    [Google Scholar]
  2. Gupta P, Balchandran R, Ho M, Enrico A, Rinaldo C. 1989; Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. Journal of Virology 63:2361–2365
    [Google Scholar]
  3. Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, Wong-Staal F. 1984; Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature, London 312:166–169
    [Google Scholar]
  4. Kim S, Byrn R, Groopman J, Baltimore D. 1989; Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. Journal of Virology 63:3708–3713
    [Google Scholar]
  5. Kim S, Ikeuchi K, Groopman J, Baltimore D. 1990; Factors affecting cellular tropism of human immunodeficiency virus. Journal of Virology 64:5600–5604
    [Google Scholar]
  6. Li P, Burrell CJ. 1992; Synthesis of human immunodeficiency virus DNA in a cell-to-cell transmission model. AIDS Research and Human Retroviruses 8:253–259
    [Google Scholar]
  7. Li P, Kuiper LJ, Stephenson AJ, Burrell CJ. 1992; De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus. Journal of General Virology 73:955–959
    [Google Scholar]
  8. Michael NL, Morrow P, Mosca J, Vahey M, Burke DS, Redfield RR. 1991; Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. Journal of Virology 65:1291–1303
    [Google Scholar]
  9. Michael NL, Vahey M, Burke DS, Redfield RR. 1992; Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. Journal of Virology 66:310–316
    [Google Scholar]
  10. Panganiban AT, Temin HM. 1983; The terminal nucleotides of retrovirus DNA are required for integration but not virus production. London 306:155–160
    [Google Scholar]
  11. Pietroboni GR, Harnett GB, Bucens MR. 1989; Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpes virus type 6 (HHV-6) infection in vitro. Journal of Virological Methods 24:85–90
    [Google Scholar]
  12. Pomerantz RJ, Frono D, Feinberg MB, Baltimore D. 1990; Cells non-productively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61:1271–1276
    [Google Scholar]
  13. Rasty S, Dhruva BR, Schillz RL, Shih DS, Issel CJ, Montelaro RC. 1990; Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections. Journal of Virology 64:86–95
    [Google Scholar]
  14. Sambrook J, Fritsch EF, Maniatis T. 1989; Molecular Cloning: A Laboratory Manual. , 2nd edn. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  15. Schuitemaker H, Koot M, Kootstra NA, Dercksen H, de Goede REY, van Steenwijk RP, Lange JMA, Schat-tenkerk JKME, Miedema F, Tersmette M. 1992; Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. Journal of Virology 66:1354–1360
    [Google Scholar]
  16. Smith MS, Brian EL, Pagano JS. 1987; Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine. Journal of Virology 61:3769–3773
    [Google Scholar]
  17. Stevenson M, Haggerty S, Lamonica CA, Meier CM, Welch SK, Wasiak AJ. 1990; Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. Journal of Virology 64:2421–2425
    [Google Scholar]
  18. Vigne R, Barban V, Querat G, Mazarin V, Gourdou I, Sauze N. 1987; Transcription of visna virus during its lytic cycle: evidence for a sequential early and late gene expression. Virology 161:218–227
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-1-33
Loading
/content/journal/jgv/10.1099/0022-1317-74-1-33
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error